Annmarie Fleshman

Annmarie Fleshman is the current Director of Quality and Compliance at Sanguine. Annmarie has over 20 years of experience in Quality Assurance and compliance, working in both the pharmaceutical and medical device industries. Prior to their current position, Ms. Fleshman served as a Quality Assurance Manager at Precision for Medicine, where they were responsible for leading inspection readiness activities, hosting external regulatory agency and notified body assessments and inspections, and managing the quality system. Ms. Fleshman has also worked as an Independent Consultant, providing quality assurance and compliance services to clients in the life sciences industry. Annmarie is a certified auditor for ISO 9001 and ISO 13485, and is also certified in Good Manufacturing Practices (GMP) by the Food and Drug Administration (FDA).

Annmarie Fleshman holds a Master's degree in Enviromental and Risk Management from the University of Maryland Global Campus. Annmarie also holds a Bachelor of Science in Biology and Environmental Science from Mount St. Mary's University. In addition, they are certified by ZenQMS as a ZenQMS Certified Administrator, by CITI Program as a Researchers (IPS), by College of American Pathologists (CAP) as an Inspection Team Leader Training, by The Global Health Network as an ICH Good Clinical Practice E6 (R2), by SkillPath as a Supervisor Professional Certification, by CALISO as an FDA's cGLP for Nonclinical Laboratory Studies, by CITI Program as a Conflicts of Interest, and by CITI Program as a Biomedical Responsible Conduct of Research.

They work with Gerald Lee - Chief Product Officer, Charlene Christman - VP, Marketing and Demand Generation, and Adam Schreck - Account Executive- West Coast. and Kat Peterson - Senior Quality Assurance Specialist reports to Annmarie Fleshman. Annmarie Fleshman reports to Brian Neman, CEO & Co-Founder.